NVSEF
Price
$124.59
Change
+$0.59 (+0.48%)
Updated
Sep 29 closing price
Capitalization
238.05B
SNYNF
Price
$91.40
Change
+$1.33 (+1.48%)
Updated
Sep 29 closing price
Capitalization
111.3B
Interact to see
Advertisement

NVSEF vs SNYNF

Header iconNVSEF vs SNYNF Comparison
Open Charts NVSEF vs SNYNFBanner chart's image
Novartis AG
Price$124.59
Change+$0.59 (+0.48%)
Volume$80.8K
Capitalization238.05B
Sanofi
Price$91.40
Change+$1.33 (+1.48%)
Volume$1.41K
Capitalization111.3B
NVSEF vs SNYNF Comparison Chart in %
Loading...
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVSEF vs. SNYNF commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVSEF is a Hold and SNYNF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 30, 2025
Stock price -- (NVSEF: $124.59 vs. SNYNF: $91.40)
Brand notoriety: NVSEF and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVSEF: 30% vs. SNYNF: 3%
Market capitalization -- NVSEF: $238.05B vs. SNYNF: $111.3B
NVSEF [@Pharmaceuticals: Major] is valued at $238.05B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $111.3B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $649.52B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVSEF’s FA Score shows that 3 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • NVSEF’s FA Score: 3 green, 2 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, NVSEF is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVSEF’s TA Score shows that 3 TA indicator(s) are bullish while SNYNF’s TA Score has 5 bullish TA indicator(s).

  • NVSEF’s TA Score: 3 bullish, 3 bearish.
  • SNYNF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNYNF is a better buy in the short-term than NVSEF.

Price Growth

NVSEF (@Pharmaceuticals: Major) experienced а +0.66% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -2.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.28%. For the same industry, the average monthly price growth was -0.62%, and the average quarterly price growth was +13.81%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.28% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVSEF($238B) has a higher market cap than SNYNF($111B). NVSEF has higher P/E ratio than SNYNF: NVSEF (18.16) vs SNYNF (15.17). NVSEF YTD gains are higher at: 29.646 vs. SNYNF (-3.891). NVSEF has higher annual earnings (EBITDA): 22.7B vs. SNYNF (12.6B). SNYNF has more cash in the bank: 15.4B vs. NVSEF (7B). SNYNF has less debt than NVSEF: SNYNF (22.3B) vs NVSEF (32.6B). NVSEF has higher revenues than SNYNF: NVSEF (55.2B) vs SNYNF (45.7B).
NVSEFSNYNFNVSEF / SNYNF
Capitalization238B111B214%
EBITDA22.7B12.6B180%
Gain YTD29.646-3.891-762%
P/E Ratio18.1615.17120%
Revenue55.2B45.7B121%
Total Cash7B15.4B45%
Total Debt32.6B22.3B146%
FUNDAMENTALS RATINGS
NVSEF vs SNYNF: Fundamental Ratings
NVSEF
SNYNF
OUTLOOK RATING
1..100
8617
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
2961
PRICE GROWTH RATING
1..100
5582
P/E GROWTH RATING
1..100
7294
SEASONALITY SCORE
1..100
6575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (4) in the null industry is in the same range as NVSEF (15). This means that SNYNF’s stock grew similarly to NVSEF’s over the last 12 months.

NVSEF's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for SNYNF (100). This means that NVSEF’s stock grew significantly faster than SNYNF’s over the last 12 months.

NVSEF's SMR Rating (29) in the null industry is in the same range as SNYNF (61). This means that NVSEF’s stock grew similarly to SNYNF’s over the last 12 months.

NVSEF's Price Growth Rating (55) in the null industry is in the same range as SNYNF (82). This means that NVSEF’s stock grew similarly to SNYNF’s over the last 12 months.

NVSEF's P/E Growth Rating (72) in the null industry is in the same range as SNYNF (94). This means that NVSEF’s stock grew similarly to SNYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSEFSNYNF
RSI
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
59%
MACD
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 7 days ago
50%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
NVSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPX3.820.08
+2.14%
Compass Therapeutics
KEY18.88-0.01
-0.05%
KeyCorp
STNG57.10-0.71
-1.23%
Scorpio Tankers
INAB2.26-0.03
-1.31%
IN8bio Inc
SKYE3.88-0.23
-5.60%
Skye Bioscience

NVSEF and

Correlation & Price change

A.I.dvisor tells us that NVSEF and SNYNF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVSEF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVSEF
1D Price
Change %
NVSEF100%
+0.48%
SNYNF - NVSEF
27%
Poorly correlated
+1.48%
SNY - NVSEF
21%
Poorly correlated
+0.24%
NVS - NVSEF
20%
Poorly correlated
+0.36%
KYKOF - NVSEF
7%
Poorly correlated
N/A
GIKLY - NVSEF
6%
Poorly correlated
N/A
More

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
+1.48%
SNY - SNYNF
37%
Loosely correlated
+0.24%
NVSEF - SNYNF
24%
Poorly correlated
+0.48%
AZN - SNYNF
23%
Poorly correlated
+0.50%
JNJ - SNYNF
22%
Poorly correlated
+1.06%
NVS - SNYNF
21%
Poorly correlated
+0.36%
More